Brian E. Hearn

Array ( [id] => 11546672 [patent_doc_number] => RE046364 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2017-04-11 [patent_title] => 'Fibrosis inhibitor' [patent_app_type] => reissue [patent_app_number] => 15/155202 [patent_app_country] => US [patent_app_date] => 2016-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 6094 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15155202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11813233 [patent_doc_number] => RE046496 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2017-08-01 [patent_title] => 'Metformin glycinate for blood glucose control' [patent_app_type] => reissue [patent_app_number] => 15/135018 [patent_app_country] => US [patent_app_date] => 2016-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11190 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15135018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11574051 [patent_doc_number] => RE046372 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2017-04-25 [patent_title] => 'Method for treating hearing loss' [patent_app_type] => reissue [patent_app_number] => 15/089849 [patent_app_country] => US [patent_app_date] => 2016-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 29 [patent_no_of_words] => 15486 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15089849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11928091 [patent_doc_number] => RE046584 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2017-10-24 [patent_title] => 'Methods and compositions for wound treatment' [patent_app_type] => reissue [patent_app_number] => 15/006882 [patent_app_country] => US [patent_app_date] => 2016-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 7070 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15006882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11610951 [patent_doc_number] => RE046402 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2017-05-16 [patent_title] => 'Bioactive scaffolds' [patent_app_type] => reissue [patent_app_number] => 14/994478 [patent_app_country] => US [patent_app_date] => 2016-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7335 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14994478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11388262 [patent_doc_number] => RE046284 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2017-01-24 [patent_title] => 'Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor' [patent_app_type] => reissue [patent_app_number] => 14/985148 [patent_app_country] => US [patent_app_date] => 2015-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4136 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14985148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11341806 [patent_doc_number] => RE046254 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2016-12-27 [patent_title] => 'Immunoreactive protein orthologs of Ehrlichia canis and E. chaffeensis ' [patent_app_type] => reissue [patent_app_number] => 14/855023 [patent_app_country] => US [patent_app_date] => 2015-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 40285 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14855023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11059593 [patent_doc_number] => 20160256553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-08 [patent_title] => 'Variants of C-Type Natriuretic Peptide' [patent_app_type] => utility [patent_app_number] => 14/660488 [patent_app_country] => US [patent_app_date] => 2015-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 74212 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14660488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12382743 [patent_doc_number] => RE046830 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-05-08 [patent_title] => Method for solid phase peptide synthesis [patent_app_type] => reissue [patent_app_number] => 14/659770 [patent_app_country] => US [patent_app_date] => 2015-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5179 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 247 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14659770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11696994 [patent_doc_number] => RE046453 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2017-06-27 [patent_title] => 'Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer' [patent_app_type] => reissue [patent_app_number] => 14/631092 [patent_app_country] => US [patent_app_date] => 2015-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 6164 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14631092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14914071 [patent_doc_number] => 10428344 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-01 [patent_title] => Nucleotide sequences and corresponding polypeptides conferring modified phenotype characteristics in plants [patent_app_type] => utility [patent_app_number] => 14/627544 [patent_app_country] => US [patent_app_date] => 2015-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 169 [patent_figures_cnt] => 169 [patent_no_of_words] => 81436 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14627544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12170500 [patent_doc_number] => RE046707 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-02-13 [patent_title] => 'Variants of C-type natriuretic peptide' [patent_app_type] => reissue [patent_app_number] => 14/604262 [patent_app_country] => US [patent_app_date] => 2015-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 85 [patent_no_of_words] => 74116 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14604262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11407207 [patent_doc_number] => RE046293 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2017-01-31 [patent_title] => 'System and method for detection of HIV tropism variants' [patent_app_type] => reissue [patent_app_number] => 14/586563 [patent_app_country] => US [patent_app_date] => 2014-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 14943 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14586563 [rel_patent_id] =>[rel_patent_doc_number] =>)